Harrow, Inc. Preferred Stock, Accretion of Redemption Discount
Harrow, Inc. (HROW) reported Preferred Stock, Accretion of Redemption Discount of $100.00 thousand for the 188-month period ending 2014-03-31, per its 10-Q filed 2014-05-15.
Discontinued › Shareholders' Equity
us-gaap:PreferredStockAccretionOfRedemptionDiscount · last filed 2014-05-15
- Harrow, Inc. preferred stock, accretion of redemption discount for the quarter ending 2013-03-31 was $0.00, a 100.00% decline year-over-year.
- Harrow, Inc. preferred stock, accretion of redemption discount for the quarter ending 2012-03-31 was $100.00K.
- Harrow, Inc. preferred stock, accretion of redemption discount for the quarter ending 2011-03-31 was $0.00.
- Harrow, Inc. preferred stock, accretion of redemption discount for fiscal 2012 was $0.00.
- Harrow, Inc. preferred stock, accretion of redemption discount for fiscal 2011 was -$100.00K.
- Harrow, Inc. preferred stock, accretion of redemption discount for fiscal 2010 was $0.00.
| Period end | Preferred Stock, Accretion of Redemption Discount 3 month | Preferred Stock, Accretion of Redemption Discount 3 month as first filed | Preferred Stock, Accretion of Redemption Discount 12 month | Preferred Stock, Accretion of Redemption Discount 161 month | Preferred Stock, Accretion of Redemption Discount 164 month | Preferred Stock, Accretion of Redemption Discount 167 month | Preferred Stock, Accretion of Redemption Discount 170 month | Preferred Stock, Accretion of Redemption Discount 173 month | Preferred Stock, Accretion of Redemption Discount 176 month | Preferred Stock, Accretion of Redemption Discount 182 month | Preferred Stock, Accretion of Redemption Discount 185 month | Preferred Stock, Accretion of Redemption Discount 188 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2014-03-31 | $100.00K 10-Q · filed 2014-05-15 | |||||||||||
| 2013-12-31 | $100.00K 10-K · filed 2014-03-28 | |||||||||||
| 2013-09-30 | $100.00K 10-Q · filed 2013-11-06 | |||||||||||
| 2013-06-30 | $100.00K 10-Q · filed 2013-08-14 | |||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2013-05-08 | $100.00K 10-Q · filed 2013-05-08 | ||||||||||
| 2012-12-31 | $0.00 10-K · filed 2013-03-18 | $100.00K 10-K · filed 2013-03-18 | ||||||||||
| 2012-09-30 | $100.00K 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $100.00K 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | $100.00K 10-Q · filed 2013-05-08 | $0.00 10-Q · filed 2012-05-10 | $100.00K 10-Q · filed 2012-05-10 | |||||||||
| 2011-12-31 | -$100.00K 10-K · filed 2014-03-28 | -$100.00K 10-K · filed 2012-02-23 | ||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-10 | |||||||||||
| 2010-12-31 | $0.00 10-K · filed 2012-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |